Sign in
WithdrawnNo phase

Dietary Cysteine and Methionine Deprivation (CMD) in Glioma Patients

Key facts

Who runs it
UNC Lineberger Comprehensive Cancer Center
Where
Chapel Hill, United StatesSee the site
Trial code
Status
Withdrawn
Started
May 2026
Expected to end
Jul 2028
Type of study
Interventional, 6 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Normal diet
  • Cysteine/methionine deprivation (CMD) diet for 2 days
  • Cysteine/methionine deprivation (CMD) diet for 4 days
Record updated
28 April 2026
Why it stopped
Not stated

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Written informed consent obtained to participate in the study and HIPAA authorization for release of personal health information
  • Subjects is willing and able to comply with study procedures based on the judgement of the investigator
  • Age ≥ 18 years at the time of consent
  • Karnofsky Performance Status of ≥ 60 assessed at diagnosis

Who cannot take part

  • Subjects with prior brain metastasis
  • Active infection requiring systemic therapy
  • Any active disease that may be associated with unacceptable anesthetic/operative risk
  • Pregnant or breastfeeding
  • Transfusion within 7 days of diet initiation

Other criteria

  • In order to participate in this study a subject must meet all of the eligibility criteria outlined below. Eligibility must be maintained up until the point at which the subject receives treatment for the subject to be considered eligible for treatment

Where in United States

  • University of North Carolina at Chapel Hill, Department of Radiation OncologyChapel Hill, United States

About the trial

What the trial wants to find out

This pilot study looks at how certain diet changes affect the body in patients with recurrent brain tumors (glioma) who are planning to have standard treatment like radiation or surgery. Up to 30 patients will be randomly assigned to either a regular diet or a special diet that limits two nutrients (cysteine and methionine) for 2, 4, or 7 days before their treatment.

Read full original descriptionShow less

Patients will be monitored for side effects using blood tests and questionnaires, and patients will keep a diary to track how well they follow the diet. Blood and urine samples will be used to see how the diet affects the body. Tumor samples (from surgery) will help researchers study how the cancer cells behave, and stool samples will be used to look at gut bacteria.

This is a randomized, blinded interventional pilot study to measure glutathione metabolite levels with a cysteine/methionine deprivation (CMD) diet in glioma patients. A menu of pre-prepared meals will be provided to subjects that consist of either a control diet or a CMD diet. The CMD diet will be implemented simultaneously in 2 cohorts of participants with recurrent glioma.

The primary objective will be to measure the metabolic state of glioblastome multiforme tumor cells through dietary restriction of the sulfur-containing amino acids (SAA), cysteine/cystine and methionine.

Patient from cohort A can later be included in Cohort B if applicable. Patients will be followed for progression free survival and overall survival for up to 1 year, or until they discontinue or are removed from the study for exploratory endpoints.

The 6 groups in the trial

  • Cohort A: Surgery ControlExisting treatment, for comparison

    Participants will undergo surgery and receive a normal diet.

    Treatment: Normal diet

  • Cohort A: Surgery Diet Restriction 2 daysTreatment being tested

    Participants will undergo surgery and receive a cysteine/methionine deprivation (CMD) diet for 2 days.

    Treatment: Cysteine/methionine deprivation (CMD) diet for 2 days

  • Cohort A: Surgery Diet Restriction 4 daysTreatment being tested

    Participants will undergo surgery and receive a cysteine/methionine deprivation (CMD) diet for 4 days.

    Treatment: Cysteine/methionine deprivation (CMD) diet for 4 days

  • Cohort B: Radiation Therapy ControlExisting treatment, for comparison

    Participants will undergo radiation therapy and receive a normal diet.

    Treatment: Normal diet

  • Cohort B: Radiation Therapy 2 daysTreatment being tested

    Participants will undergo radiation therapy and receive a a cysteine/methionine deprivation (CMD) diet for 2 days.

    Treatment: Cysteine/methionine deprivation (CMD) diet for 2 days

  • Cohort B: Radiation Therapy 4 daysTreatment being tested

    Participants will undergo radiation therapy and receive a a cysteine/methionine deprivation (CMD) diet for 4 days.

    Treatment: Cysteine/methionine deprivation (CMD) diet for 4 days

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Pilot Study Examining Dietary Restriction of Sulfur Containing Amino Acids by Cysteine and Methionine Deprivation (CMD) in Glioma Patients
Record updated
28 April 2026